Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
doi:10.1210/clinem/dgad523 Thomas J, Suarez Arbelaez M, Narasimman M, et al
Subgroup analysis was conducted using the overall cohort to maximize sample size within each subgroup
The deal covers commercialization rights for ecnoglutide in mainland China
Sources and References This review is based on publicly available information describing how the Brello Health program operates at the time of writing
N -acetylcysteine as an adjunctive treatment for bipolar depression: A systematic review and meta-analysis of randomized controlled trials"
Acta Pharm Sin B 12(11):40404055
US$ 21.90
.png)
US$ 20.94
US$ 21.59
